GSTM1 and anemia (phenotype): This large, contemporary study reports the management of anemia in a real-world cohort of >26,000 patients with NDD-CKD from multifaceted aspects, including a cross-sectional study of anemia treatment on initial Hb response and Hb fluctuations to provide comprehensive epidemiologic information on anemia management in routine clinical care.